Glutaraldehyde treatment of allograft tissue decreases allosensitization after the Norwood procedure

Journal of Thoracic and Cardiovascular Surgery

Volumn 139, Issue 6, 2010, Pages 1402-1408

  Laing, Bryce J ^a   Ross, David B ^a   Meyer, Steven R ^a   Campbell, Patricia ^a   Halpin, Anne M ^a   West, Lori J ^a   Rebeyka, Ivan M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA; GLUTARALDEHYDE; HLA ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ALLOGRAFT; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; AORTA CLAMPING; ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOPRESERVATION; FLOW CYTOMETRY; HEART ARREST; HUMAN; HUMAN TISSUE; HYPOPLASTIC LEFT HEART SYNDROME; INFANT; NORWOOD PROCEDURE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; SENSITIZATION; THROMBOCYTE TRANSFUSION;

COHORT STUDIES; CRYOPRESERVATION; FEMALE; GLUTARAL; HUMANS; HYPERSENSITIVITY; HYPOPLASTIC LEFT HEART SYNDROME; INFANT, NEWBORN; MALE; PREOPERATIVE CARE; PULMONARY ARTERY; TISSUE TRANSPLANTATION;

EID: 77952321559     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2009.12.034     Document Type: Article

References (24)

1. Stasik C.N., Gelehrter S., Goldberg C.S., Bove E.L., Devaney E.J., and Ohye R.G. Current outcomes and risk factors for the Norwood procedure. J Thorac Cardiovasc Surg 131 (2006) 412-417
2. Meyer S.R., Campbell P.M., Rutledge J.M., Halpin A.M., Hawkins L.E., Lakey J.R., et al. Use of an allograft patch in repair of hypoplastic left heart syndrome may complicate future transplantation. Eur J Cardiothorac Surg 27 (2005) 554-560
3. Hawkins J.A., Breinholt J.P., Lambert L.M., Fuller T.C., Profaizer T., McGough E.C., et al. Class I and class II anti-HLA antibodies after implantation of cryopreserved allograft material in pediatric patients. J Thorac Cardiovasc Surg 119 (2000) 324-330
4. Jacobs J.P., Quintessenza J.A., Boucek R.J., Morell V.O., Botero L.M., Badhwar V., et al. Pediatric cardiac transplantation in children with high panel reactive antibody. Ann Thorac Surg 78 (2004) 1703-1709
5. Jacobs J.P., Quintessenza J.A., Chai P.J., Lindberg H.L., Asante-Korang A., McCormack J., et al. Rescue cardiac transplantation for failing staged palliation in patients with hypoplastic left heart syndrome. Cardiol Young 16 (2006) 556-562
6. Okamura K., Chiba C., Iriyama T., Itoh T., Maeta H., Ijima H., et al. Antigen depressant effect of glutaraldehyde for aortic heterografts with a valve, with special reference to a concentration right fit for the preservation of grafts. Surgery 87 (1980) 170-176
7. Heacox A.E., Brockbank K.G., Fragale D.A., and McNally R.T. Donor criteria and procurement procedures for hearts and veins used as allograft transplants. Transplant. Proc 20 (1988) 751-752
8. Tambur A.R., Leventhal J., Kaufman D.B., Friedewald J., Miller J., and Abecassis M.M. Tailoring antibody testing and how to use it in the calculated panel reactive antibody era: the Northwestern University experience. Transplantation 86 (2008) 1052-1059
9. United Network for Organ Sharing. CPRA calculator. Available at: http://www.unos.org/resources/. Accessed July 28, 2009.
10. Kobashigawa J.A., Sabad A., Drinkwater D., Cogert G.A., Moriguchi J.D., Kawata N., et al. Pretransplant panel reactive-antibody screens. Are they truly a marker for poor outcome after cardiac transplantation?. Circulation 94 9 Suppl (1996) II294-II297
11. Baskett R.J., Ross D.B., Nanton M.A., and Murphy D.A. Factors in the early failure of cryopreserved homograft pulmonary valves in children: preserved immunogenicity?. J Thorac Cardiovasc Surg 112 (1996) 1170-1179
12. Hooper D.K., Hawkins J.A., Fuller T.C., Profaizer T., and Shaddy R.E. Panel-reactive antibodies late after allograft implantation in children. Ann Thorac Surg 79 (2005) 641-645
13. Tambur A.R., Bray R.A., Takemoto S.K., Mancini M., Costanzo M.R., Kobashigawa J.A., et al. Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection. Transplantation 70 (2000) 1055-1059
14. Shaddy R.E., and Fuller T.C. The sensitized pediatric heart transplant candidate: causes, consequences, and treatment options. Pediatr Transplant 9 (2005) 208-214
15. Gebel H.M., Bray R.A., and Nickerson P. Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: contraindication vs risk. Am J Transplant 3 (2003) 1488-1500
16. Jordan S.C., Vo A., Bunnapradist S., Toyoda M., Peng A., Puliyanda D., et al. Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients. Transplantation 76 (2003) 631-636
17. Meyer S.R., Ross D.B., Forbes K., Hawkins L.E., Halpin A.M., Nahirniak S.N., et al. Failure of prophylactic intravenous immunoglobulin to prevent sensitization to cryopreserved allograft tissue used in congenital cardiac surgery. J Thorac Cardiovasc Surg 133 (2007) 1517-1523
18. Shaddy R.E., Fuller T.C., Anderson J.B., Lambert L.M., Brinkman M.K., Profaizer T., et al. Mycophenolic mofetil reduces the HLA antibody response of children to valved allograft implantation. Ann Thorac Surg 77 (2004) 1734-1739
19. Meyer S.R., Nagendran J., Desai L.S., Rayat G.R., Churchill T.A., Anderson C.C., et al. Decellularization reduces the immune response to aortic valve allografts in the rat. J Thorac Cardiovasc Surg 130 (2005) 469-476
20. Ionescu M.I., Pakrashi B.C., Mary D.A., Bartek I.T., and Wooler G.H. Replacement of heart valves with frame-mounted tissue grafts. Thorax 29 (1974) 56-67
21. Lupinetti F.M., Tsai T.T., Kneebone J.M., and Bove E.L. Effect of cryopreservation on the presence of endothelial cells on human valve allografts. J Thorac Cardiovasc Surg 106 (1993) 912-917
22. Mitchell R.N., Jonas R.A., and Schoen F.J. Pathology of explanted cryopreserved allograft heart valves: comparison with aortic valves from orthotopic heart transplants. J Thorac Cardiovasc Surg 115 (1998) 118-127
23. Weber P.A., Jouan J., Matsunaga A., Pettenazzo E., Joudinaud T., Thiene G., et al. Evidence of mitigated calcification of the Mosaic versus Hancock Standard valve xenograft in the mitral position of young sheep. J Thorac Cardiovasc Surg 132 (2006) 1137-1143
24. Christenson J.T., Vala D., Sierra J., Beghetti M., and Kalangos A. Blood group incompatibility and accelerated homograft fibrocalcifications. J Thorac Cardiovasc Surg 127 (2004) 242-250